The clinically guided process of administering exogenous androgens to restore physiological androgen levels in deficient individuals. This application is precisely tailored based on diagnostic testing, aiming to achieve eugonadal status without inducing supraphysiological concentrations. Proper application addresses symptoms related to hypogonadism, impacting bone mineral density, lean body mass, and libido. Careful titration is necessary to balance therapeutic benefit against potential adverse effects.
Origin
This concept originates from the study of endocrinology, specifically the function of the testes and adrenal glands in producing testosterone and its metabolites. The term application reflects the translational aspect of endocrinology, moving from biochemical understanding to patient-centered treatment protocols. It is rooted in understanding the hypothalamic-pituitary-gonadal (HPG) axis feedback loops.
Mechanism
The therapy introduces exogenous androgens, bypassing insufficient endogenous production or secretion. These administered hormones bind to intracellular androgen receptors, forming a complex that translocates to the nucleus. This complex then modulates gene transcription, promoting protein synthesis and other anabolic effects characteristic of adequate androgen signaling. Effective application ensures sustained receptor saturation for optimal tissue response throughout the dosing interval.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.